miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling.

Giordano S. Migliore C , Morando E , Ghiso E , Anastasi S
EMBO Mol MEd

30
2018
Biosynthesis of the protein encoded by the c-met proto-oncogene.

Paolo Comoglio , Silvia Giordano , Maria Flavia Di Renzo , C Rosa
Oncogene 4 ( 11) 1383 -1388

196
1989
Mutations of Nrf2 are an early and frequent event in the development of rat hepatocellular carcinoma

Marta Kowalik , Silvia Menegon , Luca Quagliata , Annalisa Petrelli
The FASEB Journal 29

1
2015
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas

Asa Dahle-Smith , Zosia Miedzybrodzka , Anna Sapino , Cristina Migliore
Clinical Cancer Research 27 ( 11) 3126 -3140

2021
Microsatellite instability in Gastric Cancer: Between lights and shadows.

Filippo Pietrantonio , Silvia Giordano , Simona Corso , Elisabetta Puliga
Cancer Treatment Reviews 95 102175 -102175

1
2021
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.

Gian Luca Grazi , Isabella Manni , Sergio Anastasi , Mattia Forcato
Journal of Hepatology

25
2021
Personalized therapeutic strategies in HER2-driven gastric cancer.

Ida Rapa , Sabrina Rizzolio , Anna Sapino , Cristina Migliore
Gastric Cancer 1 -16

2021
Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients.

Antonella Campanale , Arianna Di Napoli , Marco Ventimiglia , Stefano Pileri
European Journal of Cancer 148 277 -286

2021
Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis

Philippe Gual , Silvia Giordano , Tracy A Williams , Stephane Rocchi
Oncogene 19 ( 12) 1509 -1518

153
2000
Differential requirement of the last C-terminal tail of Met receptor for cell transformation and invasiveness.

Philippe Gual , Silvia Giordano , Sergio Anguissola , Paolo Maria Comoglio
Oncogene 20 ( 39) 5493 -5502

6
2001
A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation

Sergio Anastasi , Silvia Giordano , Olga Sthandier , Giovanna Gambarotta
Journal of Cell Biology 137 ( 5) 1057 -1068

159
1997
Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review.

Rossella Reddavid , Simona Corso , Daniel Moya-Rull , Silvia Giordano
Updates in Surgery 72 ( 4) 951 -966

2
2020
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence.

Valentina Martin , Simona Corso , Paolo M. Comoglio , Silvia Giordano
Molecular Oncology 8 ( 8) 1561 -1574

12
2014
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis

Marta Anna Kowalik , Pia Sulas , Giovanna Maria Ledda-Columbano , Silvia Giordano
Oncotarget 6 ( 36) 38749 -38763

28
2015
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition

Simona Corso , Elena Ghiso , Virna Cepero , J RAFAEL Sierra
Molecular Cancer 9 ( 1) 121 -121

114
2010
Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy

J Rafael Sierra , Virna Cepero , Silvia Giordano
Molecular Cancer 9 ( 1) 75 -75

260
2010
Interplay between scatter factor receptors and B plexins controls invasive growth

Paolo Conrotto , Simona Corso , Sara Gamberini , Paolo Maria Comoglio
Oncogene 23 ( 30) 5131 -5137

215
2004
TGFα expression impairs Trastuzumab-induced HER2 downregulation

Giorgio Valabrega , Filippo Montemurro , Ivana Sarotto , Annalisa Petrelli
Oncogene 24 ( 18) 3002 -3010

110
2005
Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies

Sabrina Rizzolio , Gabriella Cagnoni , Chiara Battistini , Stefano Bonelli
Journal of Clinical Investigation 128 ( 9) 3976 -3990

33
2018
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.

Giorgio Valabrega , Sonia Capellero , Giuliana Cavalloni , Gianluca Zaccarello
Breast Cancer Research and Treatment 130 ( 1) 29 -40

43
2011